S3: Definition, Clinical Significance, and Overview

S3 Introduction (What it is)

S3 is the “third heart sound,” an extra low-frequency sound heard during cardiac auscultation.
It occurs in early diastole, shortly after the second heart sound (S2).
S3 is a clinical exam finding used in cardiology to assess hemodynamics and ventricular filling.
It is commonly discussed in the context of heart failure, volume overload, and cardiomyopathy.

Clinical role and significance

S3 matters because it can be a bedside clue to elevated filling pressures and increased volume flow into a ventricle, most often the left ventricle (LV). In many adult patients, an S3 is associated with conditions that increase early diastolic filling (for example, systolic heart failure with LV dilation), and it can support a broader clinical impression when combined with symptoms, vital signs, and other findings (e.g., pulmonary crackles, peripheral edema, jugular venous distension).

At the same time, S3 is not automatically pathologic. In children, adolescents, and some young adults, an S3 can be physiologic due to more compliant ventricles and brisk early filling. The clinical significance therefore depends on age, clinical context, and corroborating data from electrocardiogram (ECG), chest imaging, laboratory testing (e.g., natriuretic peptides), and echocardiography.

Because it is a physical exam sign, S3 also has practical diagnostic value in settings where rapid triage is needed, such as emergency or acute care, while acknowledging that exam performance varies by clinician and case.

Indications / use cases

Typical scenarios where S3 is discussed, sought, or interpreted include:

• Evaluation of suspected heart failure (acute decompensated heart failure or chronic heart failure)
• Assessment of cardiomyopathy, including dilated cardiomyopathy
• Volume overload states (e.g., significant valvular regurgitation such as mitral regurgitation or aortic regurgitation)
• Post–myocardial infarction evaluation when new systolic dysfunction is a concern
• Differentiation of dyspnea etiologies at the bedside (cardiac vs pulmonary), as part of a larger assessment
• Follow-up exams where serial physical findings are tracked alongside weight, symptoms, and echocardiographic parameters
• Assessment of right-sided filling dynamics (right ventricular S3), particularly in diseases affecting the right ventricle (RV) or pulmonary circulation

Contraindications / limitations

S3 is a physical exam finding rather than a procedure, so there are no true contraindications to “checking” for it. The closest relevant limitations include:

• Low sensitivity: an absent S3 does not rule out heart failure or elevated filling pressures
• Variable specificity: an S3 can be normal in younger patients and in some high-flow states
• Operator dependence: detection varies with clinician experience, auscultation technique, and environment
• Patient and acoustic factors: obesity, emphysema/chronic obstructive pulmonary disease (COPD), tachycardia, and ambient noise can reduce audibility
• Rhythm and rate issues: atrial fibrillation and tachycardia may blur diastolic sounds or create a “summation gallop”
• Over-reliance risk: interpreting S3 without integrating ECG, echocardiography, and clinical context can mislead

When the clinical question is high-stakes or uncertain, additional diagnostics (most commonly transthoracic echocardiography) are often more informative for ventricular function, valvular disease, and filling pressures.

How it works (Mechanism / physiology)

Physiologic principle

S3 is generated during early diastole, after S2, at the time of rapid passive ventricular filling. The classic teaching is that it results from vibrations of the ventricular walls and surrounding structures when blood enters a ventricle quickly and the ventricle reaches its elastic limit abruptly. The sound is low frequency and is best heard with the bell of the stethoscope.

Relevant cardiac anatomy and structures

Key structures and concepts involved include:

• Ventricles (LV and RV): ventricular compliance and chamber size influence S3 audibility
• Atrioventricular valves (mitral and tricuspid): S3 is not valve closure (unlike S1 and S2), but it occurs when these valves are open during filling
• Myocardium: dilated or failing myocardium may create conditions for a pathologic S3 (e.g., reduced systolic function with elevated end-diastolic volume)
• Pulmonary circulation (for RV S3): increased right-sided volume load can contribute, and right-sided sounds may vary with respiration

Onset, duration, reversibility

S3 is an instantaneous sound event rather than a sustained phenomenon, so “duration” is not typically described like it would be for a therapy. Its presence can be dynamic, changing with volume status, heart rate, loading conditions, and treatment response in heart failure—though the degree of change varies by clinician and case. It may be intermittently audible, especially when tachycardia shortens diastole.

S3 Procedure or application overview

S3 is not a procedure; it is assessed during the cardiovascular physical exam. A general workflow is:

1. Evaluation/exam – Review symptoms (e.g., dyspnea, orthopnea, reduced exercise tolerance), vitals, and signs of congestion. – Perform a systematic cardiac exam including auscultation at standard valve areas.

2. Diagnostics (as needed to support interpretation) – ECG to assess rhythm, rate, ischemia patterns, and conduction abnormalities. – Transthoracic echocardiography to evaluate left ventricular ejection fraction (LVEF), chamber size, diastolic function parameters, and valvular disease (e.g., mitral regurgitation). – Additional testing varies by clinician and case (e.g., chest radiography, natriuretic peptides).

3. Auscultation technique (core application) – Use the bell for low-frequency sounds. – For a left-sided S3, listen at the apex (mitral area), often with the patient in the left lateral decubitus position. – For a right-sided S3, listen along the lower left sternal border, and note respiratory variation (right-sided sounds may increase with inspiration).

4. Immediate checks – Confirm timing: S3 occurs after S2 in early diastole (“Ken-tuck-y” cadence is a common mnemonic). – Assess for associated findings: murmurs of regurgitation, displaced apical impulse, crackles, edema, or elevated jugular venous pressure.

5. Follow-up/monitoring – Track whether S3 persists or changes alongside symptoms, weight trends, volume status, and echocardiographic findings when available.

Types / variations

Common clinically relevant variations of S3 include:

• Physiologic vs pathologic
• Physiologic S3: more common in children, adolescents, and some young adults with compliant ventricles and brisk filling.

• Pathologic S3: more concerning in older adults, often associated with volume overload or reduced ventricular function.

• Left-sided (LV) S3 vs right-sided (RV) S3

• LV S3: typically best at the apex; often discussed in relation to left-sided heart failure, dilated cardiomyopathy, or mitral regurgitation.

• RV S3: best along the lower left sternal border; may be considered in right ventricular volume overload or pulmonary hypertension contexts, with interpretation depending on the broader exam.

• Transient vs persistent

• Some S3 findings fluctuate with hemodynamics (preload/afterload) and may be intermittently present.

• Summation gallop

• At high heart rates, S3 may blend with S4 (if present) in late diastole, creating a merged low-frequency sound. This is a descriptive bedside term rather than a separate pathology.

Advantages and limitations

Advantages:

• Rapid, bedside-accessible clue in symptomatic patients (e.g., dyspnea evaluation)
• No equipment beyond a stethoscope; useful in low-resource settings
• Can prompt timely consideration of heart failure physiology and volume status
• Provides immediate feedback that can be trended across exams
• Encourages integration with other exam findings (murmurs, JVP, edema, crackles)
• Can help prioritize confirmatory testing (e.g., echocardiography) when suspicion is raised

Limitations:

• Detection depends on examiner skill and listening conditions
• Low-frequency nature makes it easy to miss without correct technique (bell, positioning)
• Specificity varies with age and clinical context (may be normal in younger patients)
• Not sufficient alone to diagnose heart failure, valvular disease, or cardiomyopathy
• Confounded by tachycardia, irregular rhythms (e.g., atrial fibrillation), and lung disease
• Inter-observer variability is common; documentation may be inconsistent

Follow-up, monitoring, and outcomes

Monitoring around an S3 focuses on the underlying condition rather than the sound itself. Outcomes and follow-up intensity depend on factors such as:

• Severity of symptoms and hemodynamics: acute congestion and hypotension require different monitoring than stable chronic symptoms.
• Underlying diagnosis: reduced LVEF heart failure, preserved EF heart failure (HFpEF), valvular regurgitation, and cardiomyopathy have different trajectories and follow-up frameworks.
• Comorbidities: chronic kidney disease, COPD, anemia, ischemic heart disease, and arrhythmias can influence volume status, exercise tolerance, and exam findings.
• Response to therapy: an S3 may diminish as congestion improves in some patients, but changes are not uniform and interpretation varies by clinician and case.
• Echocardiographic parameters: chamber size, systolic function, diastolic indices, and valvular severity often guide longitudinal assessment more directly than auscultation alone.
• Adherence and rehabilitation participation: medication adherence, dietary patterns, and cardiac rehabilitation engagement can influence functional status and congestion trends (without implying individualized advice).

In clinical documentation, it is common to pair the presence/absence of S3 with other objective data (vital signs, weight, laboratory trends, and imaging) to reduce overinterpretation of a single physical sign.

Alternatives / comparisons

Because S3 is an exam finding, “alternatives” are other ways to assess similar physiologic questions (ventricular function and filling pressures):

• Echocardiography vs S3

• Echocardiography directly evaluates LVEF, chamber dimensions, wall motion, and valvular disease, and it can estimate filling pressures using Doppler measures. S3 is a supportive bedside clue but is less definitive.

• Natriuretic peptides (e.g., BNP/NT-proBNP) vs S3

• Natriuretic peptides can support the diagnosis of heart failure in the right context, while S3 is a physical sign that may or may not be present. Both require clinical correlation.

• Lung ultrasound/chest radiography vs S3

• These tests assess pulmonary congestion and edema patterns more directly than auscultation alone. S3 may suggest congestion physiology but does not localize lung findings.

• S3 vs S4

• S3 is linked to rapid early filling; S4 (fourth heart sound) is associated with atrial contraction against a stiff ventricle and occurs late in diastole. Both are low frequency and can be confused, especially at fast heart rates.

• Murmurs vs S3

• Murmurs reflect turbulent blood flow (often valvular stenosis/regurgitation or shunts), whereas S3 reflects a diastolic filling vibration. A patient may have both, and a murmur can suggest an anatomic cause for volume overload leading to S3 (e.g., mitral regurgitation).

Overall, S3 is best viewed as one component of a structured cardiovascular assessment rather than a standalone diagnostic endpoint.

S3 Common questions (FAQ)

Q: What exactly is S3 in plain language?
S3 is an extra “beat” sound heard with a stethoscope shortly after the normal second heart sound. It happens during early filling of a ventricle in diastole. Clinicians use it as a clue about how blood is filling the heart.

Q: Is an S3 always abnormal?
No. An S3 can be normal in children, adolescents, and some young adults. In older adults, it more often suggests underlying cardiac disease or altered loading conditions, but context matters.

Q: Does hearing an S3 mean the patient has heart failure?
Not by itself. An S3 can support the possibility of heart failure when symptoms and other signs point in that direction, but diagnosis generally relies on the full clinical picture and often echocardiography and/or laboratory testing.

Q: Is S3 associated with reduced ejection fraction (systolic dysfunction)?
It is commonly taught in association with dilated ventricles and reduced systolic function, where early filling is rapid into a compliant but overloaded chamber. However, the relationship is not absolute, and interpretation varies by clinician and case.

Q: How do clinicians distinguish S3 from other sounds like split S2 or a murmur?
Timing and quality are key. S3 occurs shortly after S2 and is low frequency (best heard with the bell), while a split S2 is two higher-frequency components at the end of systole. Murmurs are typically longer sounds that extend across part of systole or diastole.

Q: Is detecting S3 painful or does it require anesthesia?
No. S3 is detected through routine auscultation with a stethoscope, which is noninvasive and painless. No anesthesia or sedation is involved.

Q: Does evaluating an S3 have a “cost”?
Listening for S3 during a physical exam does not add a separate procedural cost in many care settings, but overall visit charges vary by institution and healthcare system. If S3 prompts further tests like echocardiography, costs vary by device, material, and institution.

Q: If an S3 is present, how long does it last?
S3 is a sound event rather than a condition, so it does not “last” like a symptom. Its presence on exam may persist, come and go, or resolve depending on hemodynamics and the underlying disease course.

Q: Are there activity restrictions just because an S3 is heard?
An S3 alone does not define activity limits. Activity guidance depends on the underlying diagnosis, symptom burden, hemodynamic stability, and clinician assessment, and therefore varies by clinician and case.

Q: How often should S3 be rechecked or monitored?
There is no single universal interval. Reassessment frequency depends on clinical stability, care setting (acute vs outpatient), and whether the underlying condition is changing; this varies by clinician and case.